The influence of the wider use of surfactant therapy on neonatal mortality among blacks and whites

New England Journal of Medicine

Volumn 334, Issue 25, 1996, Pages 1635-1640

  Hamvas, Aaron ^a   Wise, Paul H ^b   Yang, Robert K ^a   Wampler, Nina S ^b   Noguchi, Akihiko ^c   Maurer, Michael M ^d   Walentik, Corinne A ^e   Schramm, Wayne F ^f   Cole, F Sessions ^a  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ST JOHN S MERCY MEDICAL CENTER   (United States)

^e St Louis Vet Emergency Group Inc   (United States)

^f Missouri Department of Transportation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SURFACTANT;

ARTICLE; CAUCASIAN; DRUG EFFECT; DRUG USE; FOOD AND DRUG ADMINISTRATION; HUMAN; MAJOR CLINICAL STUDY; NEGRO; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; TREATMENT OUTCOME; VERY LOW BIRTH WEIGHT;

ADRENAL CORTEX HORMONES; AFRICAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; INFANT MORTALITY; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; MISSOURI; PREGNANCY; PRENATAL CARE; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 0029953829     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199606203342504     Document Type: Article

References (29)

1. Jobe AH. Pulmonary surfactant therapy. N Engl J Med 1993;328:861-8.
2. Liechty EA, Donovan E, Purohit D, et al. Reduction of neonatal mortality after multiple doses of bovine surfactant in low birth weight neonates with respiratory distress syndrome. Pediatrics 1991;88:19-28.
3. Horbar JD, Soll RF, Sutherland JM, et al. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome. N Engl J Med 1989;320:959-65.
4. Long W, Corbet A, Cotton R, et al. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. N Engl J Med 1991;325:1696-703.
5. Long W, Thompson T, Sundell H, Schumacher R, Volberg F, Guthrie R. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. J Pediatr 1991;118:595-605.
6. Merritt TA, Hallman M, Berry C, et al. Randomized, placebo-controlled trial of human surfactant given at birth versus administration in very low birth weight infants with lung immaturity. J Pediatr 1991;118:581-94.
7. Gitlin JD, Soll RF, Parad RB, et al. Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease. Pediatrics 1987;79:31-7.
8. Speer CP, Robertson B, Curstedt T, et al. Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf. Pediatrics 1992;89:13-20.
9. Wegeman ME Annual summary of vital statistics - 1992. Pediatrics 1993; 92:743-54.
10. Idem. Annual summary of vital statistics - 1991. Pediatrics 1992;90:835-45.
11. Idem. Annual summary of vital statistics - 1990. Pediatrics 1991;88:1081-92.
12. Wise PH, Kotelchuck M, Wilson ML, Mills M. Racial and socioeconomic disparities in childhood mortality in Boston. N Engl J Med 1985;313:360-6.
13. Fujikura T, Froehlich LA. The influence of race and other factors on pulmonary hyaline membranes: a report from the Collaborative Study of Cerebral Palsy. Am J Obstet Gynecol 1966;95:572-8.
14. Hulsey TC, Alexander GR, Robillard PY, Annibale DJ, Keenan A. Hyaline membrane disease: the role of ethnicity and maternal risk characteristics. Am J Obstet Gynecol 1993;168:572-6.
15. Ross S, Naeye RL. Racial and environmental influences on fetal lung maturation. Pediatrics 1981;68:790-5.
16. Olowe SA, Akinkugbe A. Amniotic fluid lecithin/sphingomyelin ratio: comparison between an African and North American community. Pediatrics 1978;62:38-41.
17. Collaborative Group on Antenatal Steroid Therapy. Effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome. Am J Obstet Gynecol 1981;141:276-87.
18. Richardson DK, Torday JS. Racial differences in predictive value of the lecithin/sphingomyelin ratio. Am J Obstet Gynecol 1994;170:1273-8.
19. National Center for Health Statistics. Advance report of final mortality statistics, 1991. Mon Vital Stat Rep 1993;42(2):Suppl.
20. National Center for Health Statistics, MacDorman MF, Rosenberg HM. Trends in infant mortality by cause of death and other characteristics. 1960-88. Vital and health statistics. Series 20. No. 20. Washington, D.C.: Government Printing Office, 1993:1-51. (DHHS publication no. (PHS) 93-1857.)
21. Martin RJ, Fanaroff AA. The respiratory distress syndrome and its management. In: Fanaroff AA, Martin RJ, eds. Neonatal-perinatal medicine: diseases of the fetus and infant. 5th ed. Vol. 2. St. Louis: Mosby-Year Book, 1992: 810-20.
22. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH consensus statement. Vol. 12. No. 2. Bethesda, Md.: National Institutes of Health, 1994:1-24.
23. The international classification of diseases. 9th rev., clinical modification: ICD-9-CM. 4th ed. Vols. 1, 2, and 3. New York: McGraw-Hill, 1994.
24. Armitage P, Berry G. Statistical methods in medical research. 2nd ed. Oxford, England: Blackwell Scientific, 1987.
25. Horbar JD, Wright EC, Onstad L. Decreasing mortality associated with the introduction of surfactant therapy: an observational study of neonates weighing 601 to 1300 grams at birth. Pediatrics 1993;92:191-6.
26. Palta M, Weinstein MR, McGuinness C, Gabbert D, Brady W, Peters ME. A population study: mortality and morbidity after availability of surfactant therapy. Arch Pediatr Adolesc Med 1994;148:1295-301.
27. Schwartz RM, Luby AM, Scanlon JW, Kellogg RJ. Effect of surfactant on morbidity, mortality, and resource use in newborn infants weighing 500 to 1500 g. N Engl J Med 1994;330:1476-80.
28. Maher JE, Cliver SP, Goldenberg RL, Davis RO, Copper RL. The effect of corticosteroid therapy in the very premature infant. Am J Obstet Gynecol 1994;170:869-73.
29. Avery ME. Historical overview of antenatal steroid use. Pediatrics 1995;95: 133-5.